BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 38016582)

  • 21. Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder.
    Hughto JMW; Moyo P; Green TC
    J Addict Med; 2022 Nov-Dec 01; 16(6):616-618. PubMed ID: 35245915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
    Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
    Reg Anesth Pain Med; 2024 May; 49(5):361-362. PubMed ID: 36427903
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems.
    Krawczyk N; Rivera BD; Basaraba C; Corbeil T; Allen B; Schultebraucks K; Henry BF; Pincus HA; Levin FR; Martinez D
    Addiction; 2023 May; 118(5):857-869. PubMed ID: 36459420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model.
    Alexander GC; Ballreich J; Mansour O; Dowdy DW
    Addiction; 2022 Apr; 117(4):969-976. PubMed ID: 34590369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
    Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
    JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis.
    Thompson K; Barocas JA; Delcher C; Bae J; Hammerslag L; Wang J; Chandler R; Villani J; Walsh S; Talbert J
    Drug Alcohol Depend; 2023 Jan; 242():109710. PubMed ID: 36469995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
    Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
    JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic.
    Tanz LJ; Jones CM; Davis NL; Compton WM; Baldwin GT; Han B; Volkow ND
    JAMA Netw Open; 2023 Jan; 6(1):e2251856. PubMed ID: 36662523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postpartum Opioid-Related Mortality in Patients With Public Insurance.
    Suarez EA; Huybrechts KF; Straub L; Hernández-Díaz S; Creanga AA; Connery HS; Gray KJ; Vine SM; Jones HE; Bateman BT
    Obstet Gynecol; 2023 Apr; 141(4):657-665. PubMed ID: 36897177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
    Crystal S; Nowels M; Samples H; Olfson M; Williams AR; Treitler P
    Drug Alcohol Depend; 2022 Mar; 232():109269. PubMed ID: 35038609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States.
    Auty SG; Griffith KN
    Drug Alcohol Depend; 2022 Mar; 232():109340. PubMed ID: 35131533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
    Kline A; Williams JM; Steinberg ML; Mattern D; Chesin M; Borys S; Chaguturu V
    J Subst Use Addict Treat; 2023 Jun; 149():209028. PubMed ID: 37003539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid use disorder-related emergency department visits among deaf or hard of hearing adults in the United States.
    Akobirshoev I; McKee MM; Reif S; Adams RS; Li FS; Mitra M
    Disabil Health J; 2022 Jun; 15(2S):101291. PubMed ID: 35346600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
    Medicaid Outcomes Distributed Research Network
    J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
    Chang CY; Jones BL; Hincapie-Castillo JM; Park H; Heldermon CD; Diaby V; Wilson DL; Lo-Ciganic WH
    Breast Cancer Res Treat; 2024 Apr; 204(3):561-577. PubMed ID: 38191684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
    Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
    J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating chronic pain as a risk factor for COVID-19 complications among New York State Medicaid beneficiaries: a retrospective claims analysis.
    Perry A; Wheeler-Martin K; Terlizzi K; Krawczyk N; Jent V; Hasin DS; Neighbors C; Mannes ZL; Doan LV; Pamplin Ii JR; Townsend TN; Crystal S; Martins SS; Cerdá M
    Pain Med; 2023 Dec; 24(12):1296-1305. PubMed ID: 37651585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
    Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.
    DiPrete BL; Ranapurwala SI; Maierhofer CN; Fulcher N; Chelminski PR; Ringwalt CL; Ives TJ; Dasgupta N; Go VF; Pence BW
    JAMA Netw Open; 2022 Apr; 5(4):e229191. PubMed ID: 35476064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.